This might be attributed to several reasons that cisplatin-resistant ovarian tumors have high expression of antioxidant proteins like H-Ferritin (Salatino et al., 2019) and signaling such as the Nrf2 pathway (Xia et al., 2014) to ameliorate oxidative stress. Here, FTH1 is linked to ovarian neoplasm.